|
The following functional tests and communications were performed: it was reported that the mother presented with concerns of no fetal movement.The nurses placed the patient on the monitor in the triage area prior to physician confirmation of fetal life via ultrasound.The fetal heart tracing displayed bradycardia between 110-120 bpm as per biomed.Subsequently, an ultrasound revealed fetal death.A philips field service engineer (fse) went onsite to test the device but found no malfunction.Additional information was provided to philips clinical and it was indicated that the mother presented with self-reported reduction in fetal movement and the fetal heartbeat could not be heard using a doppler.The patient was then connected to the monitor and the toco+ sensor was placed, revealing a base fetal heart rate (fhr) of 115 beat per minute (bpm) right below the belly button; however, the fhr could not be obtained on the left or the right.The patient indicated again there was no fetal movement, and after 13 minutes of monitoring, the mother was connected to spo2 sensor and a coincidence alarm was generated, indicating the fhr was actually the maternal heart rate (mhr).The physician examined the fetal tracing and performed an ultrasound examination, revealing fetal death.The monitors were removed from service.It was noted fetal life was not confirmed via ultrasound prior to putting the patient on the monitor.Based on this information, the monitor was obtaining mhr instead of fhr, but it also appeared fetal death had likely occurred prior to monitoring.Technical investigation results indicated that it was though fetal demise had occurred prior to the mother presenting to the hospital.It was also indicated the maternal heart rate had been captured the entire time and fetal heart rate was never captured.Based on this information, the device did not cause or contribute to the pre-existing fetal death.The investigation concludes that no further action is required at this time.
|